Viewing Study NCT02483312


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-01-04 @ 3:42 AM
Study NCT ID: NCT02483312
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2015-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module